Background illustration for clinical trials search

Paid Clinical Trials Illinois

Discover 2,591 paid clinical trials in Illinois. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Characterization of Human Olfactory Amygdala Subregions exp2

for
Changes in Olfactory Behavior Across Different Contexts Associated With Different Amygdala Subregions,
Location: Chicago IL
Sponsor: Northwestern University

Sex: All

Age: 18+

Code: NCT07074574

Recruiting

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

for
Prostate Cancer (Adenocarcinoma)
Location: Saint John, Providence RI, Saint Johnsbury VT,
Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06592924

Phase 3, Recruiting

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: New Haven CT, Quebec, New York NY, New Brunswick NJ,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase 3, Recruiting

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

for
PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC,
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: Tango Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06922591

Phase 1, Phase 2, Recruiting

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

for
Recurrent Non-Muscle Invasive Bladder Carcinoma,
Location: Peabody MA, Boston MA, Burlington MA, Commack NY,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07000084

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

for
Systemic Lupus Erythematosus (With and Without Nephritis),
Location: New York NY, East Brunswick NJ, Montreal, Baltimore MD,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07085104

Phase 1, Recruiting

INTEGRATED CHILDHOOD ACTIVITY AND NUTRITION (ICAN) STUDY

for
Achievement, Weight Change, Cognition, Fitness,
Location: Bloomington IL
Sponsor: University of Illinois at Urbana-Champaign

Sex: All

Age: 6 - 11

Code: NCT07011602

Recruiting

A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

for
Triple Negative Breast Cancer
Location: New York NY, Nashville TN, Chicago IL, Aurora CO,
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.

Sex: All

Age: 18+

Code: NCT06908928

Phase 1, Recruiting

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

for
Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis,
Location: Boston MA, Providence RI, Chicoutimi, New York NY,
Sponsor: Spyre Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07012395

Phase 2, Recruiting

A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic

for
Rheumatoid Arthritis (RA), Hidradenitis Suppurativa (HS)
Location: Boston MA, Chicago IL, Aurora CO, Stanford CA,
Sponsor: Sonoma Biotherapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07123038

Recruiting

Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study

for
Moderate Aortic Valve Stenosis
Location: Boston MA, Quebec, The Bronx NY, Albany NY, Montreal,
Sponsor: Kardigan, Inc.

Sex: All

Age: 50+

Code: NCT07001800

Phase 2, Phase 3, Recruiting

Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome

for
Netherton Syndrome
Location: Chicago IL
Sponsor: Quoin Pharmaceuticals

Sex: All

Age: 14+

Code: NCT06953466

Phase 2, Phase 3, Recruiting

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

for
Heart Transplant, Heart Failure, Transplant; Failure, Heart
Location: New York NY, Durham NC, Atlanta GA, Nashville TN,
Sponsor: XVIVO Perfusion

Sex: All

Age: 18+

Code: NCT06895070

Recruiting

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

for
Thrombocytopenia, Neonatal Alloimmune
Location: Philadelphia PA, Rochester NY, Chapel Hill NC,
Sponsor: Janssen Research & Development, LLC

Sex: Female

Age: 18 - 45

Code: NCT06533098

Phase 3, Recruiting

Effects of Effera Human Lactoferrin at One Dose Compared to Placebo on Gut Permeability

for
Gut Permeability, Gut Health
Location: Addison IL
Sponsor: Helaina Inc.

Sex: All

Age: 18 - 40

Code: NCT07035964

Recruiting

Non Inferiority Trial Investigating Surfactants Administered Via MIST

for
Respiratory Distress Syndrome
Location: Evanston IL
Sponsor: Endeavor Health

Sex: All

Age: 0

Code: NCT06074380

Recruiting

A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

for
Epileptic Encephalopathy, SCN2A Encephalopathy
Location: Philadelphia PA, Cincinnati OH, Chicago IL, Memphis TN,
Sponsor: Praxis Precision Medicines

Sex: All

Age: 0 - 18

Code: NCT07019922

Phase 3, Recruiting

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

for
Ulcerative Colitis, Obesity or Overweight
Location: London, New Bedford MA, Providence RI, Lebanon NH,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70

Code: NCT06937086

Phase 3, Recruiting

Piloting a Culturally Adapted Suicide Prevention for Black Students in Chicago

for
Suicide, Suicidal Ideation, Suicide Attempt
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 11 - 15

Code: NCT07125144

Recruiting

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

for
Crohn's Disease, Obesity or Overweight
Location: London, New Bedford MA, Providence RI, Lebanon NH,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70

Code: NCT06937099

Phase 3, Recruiting

Popular cities in Illinois

PlainfieldJolietPeoriaChicagoSpringfieldGlenviewNaperville